Two trinuclear complexes of rhodium and iridium have been obtained by reaction of the tris-N-heterocyclic carbene ligand TIMEN iPr and [(COD)MCl] 2 or [(COD) 2 M](BF 4 ) (M = Rh and Ir). The new complexes have been fully characterized by means of NMR spectroscopy and single-crystal X-ray diffraction studies. The trinuclear rhodium complex shows efficient activity in cyclization of acetylenic carboxylic acids, ranking among the highest known for this type of reaction.
No takes yet. Share an insight, caveat, or question.
Mas-Marzá et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: